Morphogenetic and Imaging Characteristics in Giant Cell Glioblastoma

Curr Oncol. 2022 Jul 28;29(8):5316-5323. doi: 10.3390/curroncol29080422.

Abstract

Giant cell glioblastoma is a rare tumor entity of IDH-wildtype glioblastoma. It is usually found in the pediatric population. We describe a particular case of a female patient diagnosed histopathologically with giant cell glioblastoma, who had two recurrences in different lobes of the same cerebral hemisphere, despite positive prognostic factors and appropriate treatment. We performed an immunohistochemical characterization of giant cell glioblastoma as well as an analysis of its aggressiveness using the cytogenetic markers TP53, CDKN2A, and TP73 using the FISH technique. The clinical picture was inconsistant, the suspicion being completely different initially. Paraclinical examination and imaging initially suggested a metastasis to the insular lobe. After surgery, histopathological and immunohistochemical examinations were the basis for the diagnosis. Despite the prognostic factors known so far in the literature, the aggressiveness denoted by multiple relapses and morphogenetic tests particularizes the case and improves the literature by bringing new information about this rare neoplasm of the central nervous system.

Keywords: CDKN2A; TP53; giant cell glioblastoma; imaging; immunohistochemistry.

Publication types

  • Case Reports

MeSH terms

  • Brain Neoplasms* / diagnostic imaging
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / pathology
  • Child
  • Female
  • Glioblastoma* / diagnostic imaging
  • Glioblastoma* / pathology
  • Humans
  • Neoplasm Recurrence, Local / diagnostic imaging

Grants and funding

This research received no external funding.